Search - tctmd.com

Displaying 21 - 40 of 236

Sort: Relevancy | Date

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

February 02, 2024

Top Endovascular News of 2023

News Daily News

Top Endovascular News of 2023

December 28, 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

November 20, 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

November 08, 2023

RADIANCE Modest Renal Denervation Effect Remains at 6 Months

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

October 31, 2023

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

News Daily News

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

October 10, 2023

TCTMD’s Top 10 Most Popular Stories for August 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

September 04, 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

August 23, 2023

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

August 22, 2023

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

August 18, 2023

August 2023 News Roundup

News Opinion CV Team Dispatch

August 2023 News Roundup

August 01, 2023

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

June 16, 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

New Data Support Tighter Air Pollution Standards to Reduce CV Events

News Daily News

New Data Support Tighter Air Pollution Standards to Reduce CV Events

February 27, 2023

NY State to Exclude Emergency PCI Cases From Public Outcomes Reports

News Daily News

NY State to Exclude Emergency PCI Deaths From Physician-Level Public Reports

January 04, 2023

Top Heart Failure News of 2022

News Daily News

Top Heart Failure News of 2022

January 04, 2023

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

November 09, 2022

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

COVID-19: TCTMD’s Dispatch for June Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 4

June 20, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.